{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:46:28Z","timestamp":1792590388225,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-024-00793-0","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T06:02:33Z","timestamp":1727676153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["TMS-evoked potentials unveil occipital network involvement in patients diagnosed with Parkinson\u2019s disease within 5 years of inclusion"],"prefix":"10.1038","volume":"10","author":[{"given":"Noa","family":"Zifman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofri","family":"Levy-Lamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avner","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftach","family":"Dolev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Mirelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilla","family":"Fogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Maidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"793_CR1","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim, T., Jette, N., Frolkis, A. & Steeves, T. D. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 29, 1583\u20131590 (2014).","journal-title":"Mov. Disord."},{"key":"793_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"793_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins, G. T. et al. How to identify tremor dominant and postural instability\/gait difficulty groups with the Movement Disorder Society Unified Parkinson\u2019s Disease Rating Scale: comparison with the Unified Parkinson\u2019s Disease Rating Scale. Mov. Disord. 28, 668\u2013670 (2013).","journal-title":"Mov. Disord."},{"key":"793_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/jnnp.2003.033530","volume":"76","author":"SJ Lewis","year":"2005","unstructured":"Lewis, S. J. et al. Heterogeneity of Parkinson\u2019s disease in the early clinical stages using a data driven approach. J. Neurol. Neurosurg. Psychiatry 76, 343\u2013348 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"793_CR5","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/brain\/awp234","volume":"132","author":"M Selikhova","year":"2009","unstructured":"Selikhova, M. et al. A clinico-pathological study of subtypes in Parkinson\u2019s disease. Brain 132, 2947\u20132957 (2009).","journal-title":"Brain"},{"key":"793_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/mds.23116","volume":"25","author":"SM Van Rooden","year":"2010","unstructured":"Van Rooden, S. M. et al. The identification of Parkinson\u2019s disease subtypes using cluster analysis: a systematic review. Mov. Disord. 25, 969\u2013978 (2010).","journal-title":"Mov. Disord."},{"issue":"Suppl 2","key":"793_CR7","first-page":"II19","volume":"249","author":"R Katzenschlager","year":"2002","unstructured":"Katzenschlager, R. & Lees, A. J. Treatment of Parkinson\u2019s disease: levodopa as the first choice. J. Neurol. 249(Suppl 2), II19\u2013II24 (2002).","journal-title":"J. Neurol."},{"key":"793_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mds.25844","volume":"29","author":"D Berg","year":"2014","unstructured":"Berg, D. et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson\u2019s disease. Mov. Disord. 29, 454\u2013462 (2014).","journal-title":"Mov. Disord."},{"key":"793_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ana.24261","volume":"76","author":"A Sieber","year":"2014","unstructured":"Sieber, A. et al. Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson\u2019s Disease 2014 conference. Ann. Neurol. 76, 469\u2013472 (2014).","journal-title":"Ann. Neurol."},{"key":"793_CR10","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/NDT.S2006","volume":"4","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. & Giselle Aguilar, L. \u201cCurrent approaches to the treatment of Parkinson\u2019s disease.\u201d. Neuropsychiatr. Dis. Treat. 4, 743\u2013757 (2008). 4.4.","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"793_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1474-4422(04)00934-2","volume":"3","author":"BL Walter","year":"2004","unstructured":"Walter, B. L. & Vitek, J. L. Surgical treatment for Parkinson\u2019s disease. Lancet Neurol. 3, 719\u2013728 (2004).","journal-title":"Lancet Neurol."},{"key":"793_CR12","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.clinph.2019.01.001","volume":"130","author":"S Tremblay","year":"2019","unstructured":"Tremblay, S. et al. Clinical utility and prospective of TMS-EEG. Clin. Neurophysiol. 130, 802\u2013844 (2019).","journal-title":"Clin. Neurophysiol."},{"key":"793_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neubiorev.2014.12.014","volume":"49","author":"M Bortoletto","year":"2015","unstructured":"Bortoletto, M., Veniero, D., Thut, G. & Miniussi, C. The contribution of TMS-EEG coregistration in the exploration of the human cortical connectome. Neurosci. Biobehav. Rev. 49, 114\u2013124 (2015).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"793_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/WCO.0b013e32832d93dd","volume":"22","author":"DS Bassett","year":"2009","unstructured":"Bassett, D. S. & Bullmore, E. T. Human brain networks in health and disease. Curr. Opin. Neurol. 22, 340\u2013347 (2009).","journal-title":"Curr. Opin. Neurol."},{"key":"793_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/35019019","volume":"406","author":"R Albert","year":"2000","unstructured":"Albert, R., Jeong, H. & Barab\u00e1si, A. L. Error and attack tolerance of complex networks. Nature 406, 378\u2013382 (2000).","journal-title":"Nature"},{"key":"793_CR16","doi-asserted-by":"publisher","first-page":"15775","DOI":"10.1523\/JNEUROSCI.3539-11.2011","volume":"31","author":"MP van den Heuvel","year":"2011","unstructured":"van den Heuvel, M. P. & Sporns, O. Rich-club organization of the human connectome. J. Neurosci. 31, 15775\u201315786 (2011).","journal-title":"J. Neurosci."},{"key":"793_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.parkreldis.2021.06.018","volume":"89","author":"I Maidan","year":"2021","unstructured":"Maidan, I. et al. A multimodal approach using TMS and EEG reveals neurophysiological changes in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 89, 28\u201333 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"793_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.parkreldis.2016.10.009","volume":"34","author":"EP Casula","year":"2017","unstructured":"Casula, E. P. et al. Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson\u2019s patients. Parkinsonism Relat. Disord. 34, 31\u201337 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"793_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/gps.4756","volume":"33","author":"N Carson","year":"2018","unstructured":"Carson, N., Leach, L. & Murphy, K. J. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int. J. Geriatr. Psychiatry 33, 379\u2013388 (2018).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"793_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0891988719874121","volume":"33","author":"O Elkana","year":"2020","unstructured":"Elkana, O., Tal, N., Oren, N., Soffer, S. & Ash, E. L. Is the cutoff of the MoCA too high? Longitudinal data from highly educated older adults. J. Geriatr. Psychiatry Neurol. 33, 155\u2013160 (2020).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"793_CR21","doi-asserted-by":"publisher","first-page":"9984419","DOI":"10.1155\/2021\/9984419","volume":"2021","author":"C Yang","year":"2021","unstructured":"Yang, C. et al. Montreal Cognitive Assessment: seeking a single cutoff score may not be optimal. Evid. Based Complement. Altern. Med. 2021, 9984419 (2021).","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"793_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neubiorev.2021.06.030","volume":"128","author":"S Pezzoli","year":"2021","unstructured":"Pezzoli, S. et al. Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson\u2019s disease and dementia with Lewy bodies: voxel-based morphometry and neuropsychological meta-analysis. Neurosci. Biobehav. Rev. 128, 367\u2013382 (2021).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"793_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/brain.2020.0985","volume":"12","author":"R Rucco","year":"2022","unstructured":"Rucco, R. et al. Brain networks and cognitive impairment in Parkinson\u2019s disease. Brain Connect. 12, 465\u2013475 (2022).","journal-title":"Brain Connect."},{"key":"793_CR24","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/brain\/awac094","volume":"145","author":"R Mehraram","year":"2022","unstructured":"Mehraram, R. et al. Functional and structural brain network correlates of visual hallucinations in Lewy body dementia. Brain 145, 2190\u20132205 (2022).","journal-title":"Brain"},{"key":"793_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","volume":"11","author":"P Svenningsson","year":"2012","unstructured":"Svenningsson, P. et al. Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment. Lancet Neurol. 11, 697\u2013707 (2012).","journal-title":"Lancet Neurol."},{"key":"793_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000363245","volume":"14","author":"AR Potgieser","year":"2014","unstructured":"Potgieser, A. R. et al. Anterior temporal atrophy and posterior progression in patients with Parkinson\u2019s disease. Neurodegener. Dis. 14, 125\u2013132 (2014).","journal-title":"Neurodegener. Dis."},{"key":"793_CR27","doi-asserted-by":"crossref","unstructured":"Rahman, M. G. M., Islam, M. M., Tsujikawa, T., Kiyono, Y. & Okazawa, H. Count-based method for specific binding ratio calculation in [I-123] FP-CIT SPECT analysis. Ann. Nucl. Med. 33, 14\u201321 (2019)..","DOI":"10.1007\/s12149-018-1297-1"},{"key":"793_CR28","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1152\/jn.00739.2010","volume":"106","author":"JO Garcia","year":"2011","unstructured":"Garcia, J. O., Grossman, E. D. & Srinivasan, R. Evoked potentials in large-scale cortical networks elicited by TMS of the visual cortex. J. Neurophysiol. 106, 1734\u20131746 (2011).","journal-title":"J. Neurophysiol."},{"key":"793_CR29","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/mds.26510","volume":"31","author":"Connie Marras","year":"2016","unstructured":"Marras, Connie & Chaudhuri, K. R. Nonmotor features of Parkinson\u2019s disease subtypes. Mov. Disord. 31, 1095\u20131102 (2016).","journal-title":"Mov. Disord."},{"key":"793_CR30","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.neuri.2022.100100","volume":"2","author":"T Samantaray","year":"2022","unstructured":"Samantaray, T., Saini, J. & Gupta, C. N. Subgrouping and structural brain connectivity of Parkinson\u2019s disease\u2013past studies and future directions. Neurosci. Inform. 2, 100100 (2022).","journal-title":"Neurosci. Inform."},{"key":"793_CR31","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/brain\/awaa019","volume":"143","author":"MC Ruppert","year":"2020","unstructured":"Ruppert, M. C. et al. Network degeneration in Parkinson\u2019s disease: multimodal imaging of nigro-striato-cortical dysfunction. Brain 143, 944\u2013959 (2020).","journal-title":"Brain"},{"key":"793_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.tins.2009.06.003","volume":"32","author":"D Eidelberg","year":"2009","unstructured":"Eidelberg, D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci. 32, 548\u2013557 (2009).","journal-title":"Trends Neurosci."},{"key":"793_CR33","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/ene.14132","volume":"27","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Grey matter abnormalities in Parkinson\u2019s disease: a voxel-wise meta-analysis,. Eur. J. Neurol. 27, 653\u2013659 (2020).","journal-title":"Eur. J. Neurol."},{"key":"793_CR34","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/mds.23291","volume":"25","author":"LK Teune","year":"2010","unstructured":"Teune, L. K. et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov. Disord. 25, 2395\u20132404 (2010).","journal-title":"Mov. Disord."},{"key":"793_CR35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"793_CR36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/mds.22875","volume":"25","author":"YJ Zhao","year":"2010","unstructured":"Zhao, Y. J. et al. Progression of Parkinson\u2019s disease as evaluated by Hoehn and Yahr stage transition times. Mov. Disord. 25, 710\u2013716 (2010).","journal-title":"Mov. Disord."},{"key":"793_CR37","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops, S. et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73, 1738\u20131745 (2009).","journal-title":"Neurology"},{"key":"793_CR38","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.clinph.2015.02.001","volume":"126","author":"PM Rossini","year":"2015","unstructured":"Rossini, P. M. et al. Noninvasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an IFCN Committee. Clin. Neurophysiol. 126, 1071\u20131107 (2015).","journal-title":"Clin. Neurophysiol."},{"key":"793_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fnagi.2019.00248","volume":"11","author":"N Zifman","year":"2019","unstructured":"Zifman, N. et al. Introducing a novel approach for evaluation and monitoring of brain health across life span using direct non-invasive brain network electrophysiology. Front. Aging Neurosci. 11, 248 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"793_CR40","doi-asserted-by":"publisher","first-page":"699014","DOI":"10.3389\/fneur.2021.699014","volume":"12","author":"H Fogel","year":"2021","unstructured":"Fogel, H. et al. Brain network integrity changes in subjective cognitive decline: a possible physiological biomarker of dementia. Front. Neurol. 12, 699014 (2021).","journal-title":"Front. Neurol."},{"key":"793_CR41","doi-asserted-by":"publisher","first-page":"589107","DOI":"10.3389\/fnins.2020.589107","volume":"14","author":"O Levy-Lamdan","year":"2020","unstructured":"Levy-Lamdan, O. et al. Evaluation of white matter integrity utilizing the DELPHI (TMS-EEG) system. Front. Neurosci. 14, 589107 (2020).","journal-title":"Front. Neurosci."},{"key":"793_CR42","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","volume":"93","author":"Yoav Benjamini","year":"2006","unstructured":"Benjamini, Yoav, Krieger, A. M. & Yekutieli, D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika 93, 491\u2013507 (2006).","journal-title":"Biometrika"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00793-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00793-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00793-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T07:04:30Z","timestamp":1727679870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00793-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1038\/s41531-024-00793-0","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"9 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.Z., O.L.L., T.H., I.D. and H.F. work in QuantalX and declare no non-financial competing interests. M.L.H. is a paid consultant for QuantalX and declares no non-financial competing interests. The rest of the authors declare no financial or non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}